Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H24N2.ClH |
| Molecular Weight | 316.868 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C(CN1CCCC1)N(CC2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=HLKYILQQGSUEJS-UHFFFAOYSA-N
InChI=1S/C19H24N2.ClH/c1-3-9-18(10-4-1)17-21(19-11-5-2-6-12-19)16-15-20-13-7-8-14-20;/h1-6,9-12H,7-8,13-17H2;1H
| Molecular Formula | C19H24N2 |
| Molecular Weight | 280.4073 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/13421807
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13421807
Histapyrrodine was investigated as a neuro-sedative drug for the treatment of anxiety and states of aggression.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:45:45 GMT 2025
by
admin
on
Mon Mar 31 18:45:45 GMT 2025
|
| Record UNII |
1W1AQ870ZC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70976647
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
1W1AQ870ZC
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
C97699
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
C049920
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
6113-17-3
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
228-079-9
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
160809
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
SUB02526MIG
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | |||
|
m762
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000086704
Created by
admin on Mon Mar 31 18:45:45 GMT 2025 , Edited by admin on Mon Mar 31 18:45:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |